GLP-1s. Semaglutide. Tirzepatide. Everybody's talking about them — but who's breaking it down for us? Get the facts, the cost, and the safe way to start.

“If we don't translate this conversation, somebody else will — and they won't do it right.”
Peptides are short chains of amino acids — the same building blocks your body already uses. The class everyone's talking about right now is GLP-1s, like semaglutide and tirzepatide. They were developed for type 2 diabetes, and turned out to also help with appetite regulation and weight management — under a provider's care.
They're not magic. They're not for everyone. And they're not the same thing as the unregulated peptides you see on random websites. We'll walk you through the difference.
Read the full breakdown
Only a licensed provider can answer that for you. But here's who's usually exploring this conversation:
Three steps. No rush. The goal is informed, not impulsive.
Start with our plain-language guides. No jargon, no fear-mongering, no hype.
Read the guidesWhen you're ready, we'll point you to a vetted telemedicine partner.
See your optionsPlain-language explainer of peptides, GLP-1s, and the difference between research and prescription versions.
The local telehealth landscape, red flags to watch for, and questions to ask any provider.
Recent FDA guidance, cost comparisons, and who each option is actually for.
Not a sales pitch. Not a quiz funnel. Just a vetted telemedicine partner who can actually evaluate whether this is right for you.
See your options